Get started

Glaxosmithkline

SWING IDEA - GLAXO SMITHKLINE PGlaxoSmithKline Pharmaceuticals , a major player in the pharmaceutical industry, is displaying technical signals that suggest a potential swing trade opportunity. Reasons are listed below : Breakthrough of Strong Resistance (1800-1900) : The 1800-1900 range was a significant resistance level. The price has broken through, retested, and is now making new highs, indicating strong bullish momentum. Breaking a 9+ Year Consolidation Phase : The stock has emerged from a consolidation phase that lasted over 9 years, signaling a potential new long-term bullish trend. Bullish Engulfing Candle on Weekly Timeframe : The recent bullish engulfing candle on the weekly chart indicates a significant shift towards bullish sentiment, engulfing the previous week's candle and suggesting further upward movement. 0.5 Fibonacci Support : The stock has found support at the 0.5 Fibonacci retracement level, reinforcing the potential for a continued bullish trend after a retracement. Increased Volumes : A noticeable increase in trading volumes confirms the strength of the price move, indicating strong investor interest and participation in the current trend. Trading at All-Time High : The stock is trading at its all-time high, suggesting strong market confidence and the potential for further gains. However, it's also important to monitor for signs of overextension or profit-taking at these levels. Target - 2940 // 3600 Stoploss - weekly close below 1950 DISCLAIMER - Decisions to buy, sell, hold or trade in securities, commodities and other investments involve risk and are best made based on the advice of qualified financial professionals. Any trading in securities or other investments involves a risk of substantial losses. The practice of "Day Trading" involves particularly high risks and can cause you to lose substantial sums of money. Before undertaking any trading program, you should consult a qualified financial professional. Please consider carefully whether such trading is suitable for you in light of your financial condition and ability to bear financial risks. Under no circumstances shall we be liable for any loss or damage you or anyone else incurs as a result of any trading or investment activity that you or anyone else engages in based on any information or material you receive through TradingView or our services. @visionary.growth.insights
NSE:GLAXOLong
by Visionary_Growth_Insights
Glaxosmithkline looking good. GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company. Their product offering include vaccines, speciality medicines & general medicines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease and respiratory diseases. GlaxoSmithKline Pharmaceuticals CMP is 1390.95. Negative aspects of the company are high valuation (P.E = 38.6), declining annual net profit & MFs are decreasing stake. Positive aspects of the company are improving cash from operations, no debt & zero promoter pledge. Entry after closing above 1402. Targets in the stock will be 1435 & 1461. Long term target in the stock will be 1489. Stop loss in the stock should be maintained at closing below 1288.
NSE:GLAXOLong
by Happy_Candles_Investment
GSK Death Cross my be hugely bullish after all !GlaxoSmithKlein (GSK) just formed a Death Cross on the 1D time-frame, which is when the 1D MA50 (blue trend-line) crosses below the 1D MA200 (orange trend-line). This is technically a bearish pattern but last time it formed (March 24 2020) was exactly on the bottom of the COVID crash and the price recovered rapidly. That was of course in the aftermath of the massive economic package in an attempt to support the economy from the lockdown but even now there is upside potential and some levels to consider on the short-term. As you see, since April 11, the stock has been trading within a perfect Channel Down. This indicates a systematic downtrend. As long as the 1D MA50 holds, such rises are sell opportunities towards a Lower Low, in which case its on the 0.236 now. Since we are trading so close to the 1D MA50, a tight sell now with the SL located at the top of the Channel Down, has an excellent Risk/ Reward ratio. Similarly, if the price breaks above the top of the Channel Down, the R/R is favorable in going on a tight buy targeting the upper Fibs and ultimately the 47.00 Resistance. Notice how the 1D RSI bounced off near the 30.00 oversold level, which has initiated massive rebounds another 4 times within the long-term Channel Up. -------------------------------------------------------------------------------------------------------- ** Please support this idea with your likes and comments, it is the best way to keep it relevant and support me. ** --------------------------------------------------------------------------------------------------------
NYSE:GSK
by TradingShot
1
Another Big Pharma Finding The BottomBased on historical movement, the trough could occur anywhere in the larger red box. The final targets are in the green boxes. The pending top should occur within the larger green box as has been the historical case. Half of all movement has ended in the smaller green box. In this instance, the signal indicated BUY on September 17, 2021 with a closing price of 38.93. If this instance is successful, that means the stock should rise to at least 39.62 which is the bottom of the larger green box. Three-quarters of all successful signals have the stock rise 4.748% from the signal closing price. This percentage is the bottom of the smaller green box. Half of all successful signals have the stock rise 6.534% which is the end point of the black dotted arrow. One-quarter of all successful signals have the stock rise 9.869% from the signal closing price which is the top of the smaller green box. The maximum rise on record would see a move to the top of the larger green box. These are the same concepts for the levels in the red boxes as well. The ends/vertical sides of the boxes are determined in a similar fashion. The peak of the rise can occur as soon as the next trading bar after signal close, while the max rise occurs within the limit of study at 35 trading bars after the signal. A 1% rise must occur over the next 35 trading bars in order to be considered a success. Three-quarters of successful movement occur after at least 20 trading bars; half occur within 30 trading bars, and one-quarter require at least 33 trading bars. The black dotted arrow represents median historical movement. Medians are a good metric, but they are just one of many I use when forecasting future movement. As always, the stock could decline the very next bar after the signal without looking back (therefore the red boxes would not come into play) or the stock may never decline (and the green boxes may never come into play).
NYSE:GSKLong
by StockSignaler
GLAXO SMITHKLINE BULLISH BUTTERFLY 33 minutes ago Hello Welcome to this analysis about GLAXO SMITHKLINE, we are looking at daily timeframe perspectives. GLAXO SMITHKLINE in recent times heavily decreased with bearishness however it now moved into an oversold condition. GLAXO SMITHKLINE is developing here that will be a decisive factor in the upcoming times. I discovered the main formation GLAXO SMITHKLINE is developing here that will be a decisive factor in the upcoming times. As when looking at my chart now we can watch there how GLAXO SMITHKLINE has emerged with this key BULLISH BUTTERFLY PATTERN marked in my chart with the black boundaries. GLAXO SMITHKLINE is near support region which is an important support and also psychological support-mark together with the lower-boundary of the BULLISH BUTTERFLY PATTERN a pullback In this manner, thank you for watching my update-analysis about GLAXO SMITHKLINE and its major BULLISH BUTTERFLY PATTERN with the determining factors we need to consider in upcoming times, support the analysis with a like and follow or comment for more market insight!
NSE:GLAXOLong
by shanechart
Big Pharma comparative analysis ---> a great time for them now ?Timestamp (black vertical line) : Mar 1 2020 ---> Lockdowns worldwide due to Covid-19 - - - - - - - - - - - - - - - - - - - - - - - - - - - GlaxoSmithKline plc (GSK) LSE:GSK GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical company headquartered in Brentford, England. Price decrease of 9.50% - - - - - - - - - - - - - - - - - - - - - - - - - - - Sorrento Therapeutics Inc. NASDAQ:SRNE Sorrento Therapeutics, Inc. is a biopharmaceutical company. It is based San Diego (Calif.), USA Price increase of 230% - - - - - - - - - - - - - - - - - - - - - - - - - - - As an ever greater number of companies seek to provide vaccines and enter the lucrative race of who will provide what and who will be awarded plush government contracts, we can see that not all Big Pharma stocks are shining, pricewise. Time will tell but if hindsight can teach us something, it is that whoever invested in this rather obscure and not well known company called 'Sorrento Therapeutics", the investment would have been more rewarding than a comparable investment into GlaxoSmithKline plc. Words of wisdom: if you have extra cash lying around, do a careful and thorough analysis first. That is true, at all time, and even more so now, in this Covid-branded and forever altered world. Francois Normandeau Institutional Research Director for ADX-BRIEFING P.S. Live Stream on TradingView on Friday, January 1, 2021, at 6 am NY time, open to all. See you there.
S
by Pine_Academy